(Click the link to comment and to vote – voting not working through email, sorry!)

COVID is on the rise again, with a more transmissible and immune-evading variant. Nirmatrelvir-ritonavir (brand name Paxlovid) is approved for children 12 years and older AND weighing 40 kg or more in high-risk situations.

Which of the following is considered a high-risk indication?